Ankylosing Spondylitis

Cardiometabolic and Mortality Risks in Chronic Inflammatory Disorders

Cardiometabolic and Mortality Risks in Chronic Inflammatory Disorders

Certain inflammatory disorders may increase the risk for cardiometabolic events and all-cause mortality.

Remicade Biosimilar FDA-Approved

Remicade Biosimilar FDA-Approved

By

The FDA has approved Renflexis, the second approved biosimilar to Remicade.

Revised Axial Spondyloarthritis Management Recommendations

Revised Axial Spondyloarthritis Management Recommendations

By

Revised recommendations for the management of patients with axial spondyloarthritis have been issued jointly by the Assessment of SpondyloArthritis International Society and the European League Against Rheumatism.

Sign Up for Free e-Newsletters